🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Thyroid Cancer Patients

GETNE Registration of Thyroid Cancer NCT03765333n/a1 site📍 Barcelona Grupo Espanol de Tumores Neuroendocrinos Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health HRQOL in Thyroid Cancer and Thyroid Tumours NCT03676348n/a1 site📍 Oslo Oslo University Hospital Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer NCT05783323Phase 26 sites📍 San Francisco📍 Boston📍 Philadelphia Children's Hospital of Philadelphia · Tests: Larotrectinib monotherapy, 131I therapy Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer NCT07068542NA1 site📍 Hangzhou Zhejiang Provincial People's Hospital · Tests: Sacituzumab Tirumotecan (SKB264) plus Tislelizumab, Sacituzumab Tirumotecan (SKB264) Thyroid Carcinoma in Cancer Patients Undergoing Radiotherapy NCT07473518n/a2 sites📍 Bologna📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases NCT03093909Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Gemcitabine Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors NCT07545837NA1 site📍 Jacksonville Mayo Clinic · Tests: Counseling, Interview, Questionnaire Administration A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer NCT07225309NA2 sites📍 New York📍 Mexico City Memorial Sloan Kettering Cancer Center · Tests: Meaning-Centered Psychotherapy for Latinos /MCP-L Health-Related Quality of Life and Emotions in Patients with Thyroid Nodules NCT06610604n/a1 site📍 Beijing Ming-an Yu · Tests: thermal ablation, thyroidectomy Study of the Prevalence of Osteo-metabolic Complications in Patients With Thyroid Cancer NCT06627998n/a1 site📍 Milan IRCCS San Raffaele · Tests: Diagnostic (chest x-ray /DXA)and clinical data collected for clinical practice Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors NCT07006727Phase 18 sites📍 Iowa City📍 Boston📍 Royal Oak Novartis Pharmaceuticals · Tests: 225Ac-ETN029, 111In-ETN029 A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma NCT06860971Phase 335 sites📍 Hefei📍 Beijing📍 Chongqing Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Tests: AL2846 Capsules, AL2846 Placebo Targeted Therapy to Increase RAI Uptake in Metastatic DTC NCT05024929n/a9 sites📍 San Francisco📍 Atlanta📍 Boston Children's Hospital of Philadelphia · Tests: Whole body scan DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. NCT07440290Phase 2, Phase 327 sites📍 Belfast📍 Birmingham📍 Birmingham Cancer Research UK · Tests: Dabrafenib, Trametinib Comparative Study of Transaxillary Robotic Thyroidectomy With MRND Versus Conventional Open Surgery in N1b PTC NCT06623578NA1 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: robotic-assisted surgery, Open Surgery Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer NCT06431620NA1 site📍 Nanjing Nanjing First Hospital, Nanjing Medical University · Tests: Recombinant Human Thyroid Stimulating Hormone Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up NCT04290663Phase 329 sites📍 Pointe à Pitre📍 Angers📍 Angers Centre Francois Baclesse · Tests: Systematic RAI-treatment, Decision of RAI-treatment guided by a post-operative assessment The EMIRATES Study NCT06855680n/a1 site📍 Wigan Royal Marsden NHS Foundation Trust Evaluation of Thyroid Abnormity Incidence and Thyroid Toxicity During Chemotherapy Among Newly Diagnosed Breast Cancer NCT03177902n/a1 site📍 Bengbu The First Affiliated Hospital of Bengbu Medical University · Tests: Chemotherapy Radiofrequency Ablation Study in LatinX Patients NCT05903196NA1 site📍 New York Northwell Health · Tests: Mygen V-1000 RF system Lateral Cervical Node Dissection in Differentiated Thyroid Cancer. NCT06149637NA1 site📍 Medellín Centro de Excelencia en Enfermedades de Cabeza y Cuello · Tests: Traditional neck dissection approach, Anterior neck dissection approach Assessing Patient Satisfaction and Confidence After Use of Educational Video to Augment Surgical Consent for Thyroid Surgery NCT06918223NA1 site📍 Philadelphia Thomas Jefferson University · Tests: Thyroid Informed Surgical Consent Augmenting Video (TISCAV), Standard Consent A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements NCT03093116Phase 1, Phase 2165 sites📍 Duarte📍 Glendale📍 La Jolla Turning Point Therapeutics, Inc. · Tests: Oral repotrectinib (TPX-0005) I-124 PET/CT Imaging and Dosimetry for RAI-Naïve or Refractory Thyroid Cancer NCT06443866n/a1 site📍 North Miami Miami Cancer Research Center, Inc. · Tests: Disease status detection, Theranostic dosimetry, I-124 PET/CT imaging Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors NCT04119024Phase 13 sites📍 Duarte📍 Los Angeles📍 Stanford Anusha Kalbasi · Tests: Biopsy, Biospecimen Collection, Computed Tomography, Cyclophosphamide, Fludarabine Phosphate Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment NCT06405217NA1 site📍 Nanjing Nanjing First Hospital, Nanjing Medical University · Tests: Recombinant Human Thyroid Stimulating Hormone Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer NCT06980103NA3 sites📍 Washington D.C.📍 Washington D.C.📍 Falls Church Georgetown University · Tests: Decision Aid, Usual Care Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE) NCT06458036Phase 25 sites📍 San Francisco📍 Philadelphia📍 Memphis Children's Hospital of Philadelphia · Tests: Selpercatinib Monotherapy, 131I Therapy A Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer NCT07287748Phase 11 site📍 Kashiwa Alpha Fusion Inc. · Tests: [211At]NaAt
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy